And [being a] compounding pharmacy is not a license to create unapproved new drugs. Nonprofit research and education organization the Center for Medicine in the Public Interest recommended in a July 2025 report that the FDA increase enforcement against companies doing this
In one trial, participants using Semaglutide GLP-1 for 68 weeks experienced an average weight loss of 14.9%, including significant reductions in abdominal fat
The caveat: large randomized controlled trial data exists for brand tirzepatide, not for compounded versions specifically
GLP-1 medications are known for their appetite-suppressing effects, which can alter familiar hunger cues
You can have a virtual visit with a doctor anytime, from anywhere
Injection site options include: - Back of arm - Belly (stay more than 1-2 inches AWAY from belly button) - Fatty part of thigh Administer the Injection: Most patients feel more comfort pinching the injection site for this step